Press release
Pediatric Growth Hormone Deficiency Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Pediatric Growth Hormone Deficiency
The increasing prevalence of pediatric diseases is expected to drive the growth of the pediatric growth hormone deficiency (GHD) market. Pediatric diseases are medical conditions primarily affecting children, ranging from infancy to adolescence. The rise in pediatric diseases is attributed to environmental factors, better detection methods, lifestyle changes, genetic predispositions, and increasing rates of chronic conditions and allergies among children. These diseases can contribute to pediatric GHD by affecting the hypothalamus or pituitary gland, which are responsible for producing growth hormone. For instance, the United Nations Children's Fund (UNICEF) reported that in 2022, approximately 4.9 million children under the age of five lost their lives, with leading causes including infectious diseases and complications from preterm birth. The increasing prevalence of pediatric diseases will drive the growth of the pediatric growth hormone deficiency market as healthcare providers focus on diagnosing and treating GHD in children.
Get Your Pediatric Growth Hormone Deficiency Market Report Here:
https://www.thebusinessresearchcompany.com/report/pediatric-growth-hormone-deficiency-global-market-report
What Is the projected market size and growth rate for the pediatric growth hormone deficiency market?
The pediatric growth hormone deficiency market has seen strong growth, increasing from $3.80 billion in 2024 to $4.16 billion in 2025 at a CAGR of 9.4%. Contributing factors include increased awareness regarding treatment, improved diagnostic capabilities, increased investment in next-generation products, and stronger public insurance coverage.
The pediatric growth hormone deficiency (PGHD) market is expected to expand significantly, reaching $5.88 billion by 2029, with a CAGR of 9.1%. Growth drivers include enhanced healthcare infrastructure and accessibility, advancements in growth hormone therapies, heightened awareness and advocacy, supportive government policies, and increasing PGHD prevalence. Key trends include novel therapy development, personalized treatment options, innovative product advancements, telemedicine and remote monitoring adoption, and genetic testing integration in treatment plans.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21250&type=smp
What new trends are reshaping the pediatric growth hormone deficiency market and its opportunities?
In the pediatric growth hormone deficiency market, companies are advancing with long-acting, once-weekly human growth hormone analogs to enhance patient compliance. For example, in June 2023, Pfizer Inc. and OPKO Health Inc. launched NGENLA (somatrogon-ghla), a once-weekly growth hormone analog approved for treating growth failure in pediatric patients with growth hormone deficiency. This treatment reduces the burden of daily injections, improving convenience for children and their families, while delivering similar efficacy to daily growth hormone treatments.
What major market segments define the scope and growth of the pediatric growth hormone deficiency market?
The pediatric growth hormone deficiency market covered in this report is segmented -
1) By Type: Congenital GH Deficiency, Acquired GH Deficiency, Idiopathic GH deficiency
2) By Product: Recombinant Human Growth Hormone (rhGH), Human Growth Hormone (HGH) Analogs, Long-Acting Growth Hormones
3) By Route Of Administration: Subcutaneous, Intramuscular, Oral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader Willi Syndrome, Other Applications
Subsegments:
1) By Congenital GH Deficiency: Isolated GH Deficiency, Combined Pituitary Hormone Deficiency
2) By Acquired GH Deficiency: GH Deficiency Due To Pituitary Tumors, GH Deficiency Due To Brain Injury, GH Deficiency Due To Radiation Therapy
3) By Idiopathic GH Deficiency: Primary Idiopathic GH Deficiency, Secondary Idiopathic GH Deficiency
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21250
Which region dominates the pediatric growth hormone deficiency market?
North America was the largest region in the pediatric growth hormone deficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric growth hormone deficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the pediatric growth hormone deficiency industry growth?
Major companies operating in the pediatric growth hormone deficiency market are Pfizer Inc., Eli Lilly and Company, Novo Nordisk A/S, Genentech Inc., Merck KGaA Darmstadt Germany, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., I-Mab Biopharma Co. Ltd., Ipsen Pharma, Gedeon Richter Plc, Ferring Pharmaceuticals, Celltrion Healthcare Co. Ltd., OPKO Health Inc., Zhejiang Hisun Pharmaceutical Co., Ltd., Dong-A ST Co. Ltd., Ascendis Pharma A/S, AnkeBio, Versartis Inc., Changchun Changsheng Life Sciences Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21250&type=smp
What Is Covered In The Pediatric Growth Hormone Deficiency Global Market Report?
•Market Size Forecast: Examine the pediatric growth hormone deficiency market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the pediatric growth hormone deficiency market for a structured understanding.
•Key Players Overview: Analyze major players in the pediatric growth hormone deficiency market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pediatric growth hormone deficiency market.
•Segment Contributions: Evaluate how different segments drive overall growth in the pediatric growth hormone deficiency market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pediatric growth hormone deficiency market.
•Industry Challenges: Identify potential risks and obstacles affecting the pediatric growth hormone deficiency market.
•Competitive Landscape: Review strategic developments in the pediatric growth hormone deficiency market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pediatric Growth Hormone Deficiency Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here
News-ID: 3934323 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Deficiency
Iron Deficiency And Iron Deficiency Anaemia Treatment Market Size Trends and For …
According to Market Research Intellect, the global Iron Deficiency And Iron Deficiency Anaemia Treatment market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for treating iron deficiency and iron deficiency anaemia is growing steadily…
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, …
As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Iron Deficiency Anemia in the 7MM.
DelveInsight's "Iron Deficiency Anemia Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/iron-deficiency-anemia-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Iron Deficiency Anemia market size,…
Coagulation Factor Deficiency Market Bridging the Gap: A Growing Coagulation Fac …
Coagulation Factor Deficiency Market worth $9.60 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Coagulation Factor Deficiency Market- (By Deficiency Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Factor XI Deficiency, Factor XIII Deficiency, and Others), By Product Type (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Biologics, Desmopressin, and Others),
By End…
Alpha-1 Antitrypsin Deficiency and Lung Health Beyond Deficiency Breathing New L …
Alpha 1 Lung Disease Market to Record an Exponential CAGR of 19.33% by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Alpha 1 Lung Disease Market - (By Disease Type (Alpha-1 Antitrypsin Deficiency, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Fibrosis, Bronchiectasis, Others), By Treatment Type (Augmentation Therapy, Bronchodilators, Corticosteroids, Oxygen Therapy, Lung Transplantation, Others),
By…
Global Iron Deficiency Anaemia Treatment Market to be Driven by the Rising Preva …
The 'Global Iron Deficiency Anaemia Treatment Market Size, Report and Forecast 2023-2031' by Expert Market Research gives an extensive outlook of the global iron deficiency anaemia treatment market, assessing the market on the basis of its segments like drug type, route of administration, treatment channel, and major regions.
Iron Deficiency Anaemia Treatment Market Size, Share, Price Trends, Industry Report, Key Players, Major Segments, and Forecast
The key highlights of the report include:
Market…
Growth Hormone Deficiency (GHD) Treatment Market
Growth Hormone Deficiency (GHD) Treatment Market: Overview
The growth hormone deficiency (GHD) treatment market has made some notable strides on the back of the growing role of GH replacement therapy in managing GHD in adults. Advances in understanding clinical syndrome of GHD and understanding of diagnosis are key trends boosting the GHD treatment market. Clinical practices pertaining to pharmacological management of the syndrome in the GHD treatment market have made remarkable…
